View Exam | PowerPak

1. Which therapy was tested in the REDUCE-IT trial?

A. Evolocumab B. Icosapent ethyl C. Fenofibrate D. EPA and DHA

2. What triglyceride lower level is recommended by multiple professional society guidelines to consider treatment with icosapent ethyl to reduce the risk of ASCVD events?

A. 70 mg/dL B. 100mg/dL C. 135 mg/dL D. 200 mg/dL

3. Which of the following statements is true concerning dietary supplement fish oil products?

A. FDA regulates their content and purity following Good Manufacturing Practices B. FDA approved them to treat severe hypertriglyceridemia (TG > 500 mg/dL) C. They may contain nontrivial quantities of saturated fats D. Labelled content of EPA and DHA is most often the same as actual content

4. Which of the following is NOT a marine omega-3 fatty acid?

A. Alpha-linolenic acid B. Eicosapentaenoic acid C. Docosapentaenoic acid D. Docosahexaenoic acid

5. Which of the following omega-3 fatty acids has been shown to preserve membrane structure and normal distribution of cholesterol?

A. α-linoleic acid (ALA) B. Eicosapentaenoic acid (EPA) C. Docosahexaenoic acid (DHA) D. All of the above

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which therapy was tested in the REDUCE-IT trial?

2. What triglyceride lower level is recommended by multiple professional society guidelines to consider treatment with icosapent ethyl to reduce the risk of ASCVD events?

3. Which of the following statements is true concerning dietary supplement fish oil products?

4. Which of the following is NOT a marine omega-3 fatty acid?

5. Which of the following omega-3 fatty acids has been shown to preserve membrane structure and normal distribution of cholesterol?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which therapy was tested in the REDUCE-IT trial?

2. What triglyceride lower level is recommended by multiple professional society guidelines to consider treatment with icosapent ethyl to reduce the risk of ASCVD events?

3. Which of the following statements is true concerning dietary supplement fish oil products?

4. Which of the following is NOT a marine omega-3 fatty acid?

5. Which of the following omega-3 fatty acids has been shown to preserve membrane structure and normal distribution of cholesterol?

« Return to Activity

Customers who Purchased
this Activity also Purchased